about
Compensatory Postural Adjustments in an Oculus Virtual Reality Environment and the Risk of Falling in Alzheimer's Disease.Application of Machine Learning in Postural Control Kinematics for the Diagnosis of Alzheimer's Disease.Postural stability analysis with inertial measurement units in Alzheimer's disease.POLG1-related levodopa-responsive parkinsonism.How do cognitive and axial motor signs correlate in Parkinson's disease? A 6-year prospective study.Role of Tc-Sulesomab Immunoscintigraphy in the Management of Infection following Deep Brain Stimulation Surgery.Deep Brain Stimulation of the Subthalamic Nucleus for Parkinson's Disease in a Patient with HIV Infection: Dual Clinical Benefit.Different protocols for analyzing behavior and adaptability in obstacle crossing in Parkinson's disease.Predictors and Moderators of Quality of Life in Alzheimer's Disease Patients.Safinamide: a new hope for Parkinson's disease?Suicide attempts after subthalamic nucleus stimulation for Parkinson's disease.Mild Left Ventricular Hypertrophy Unravels a Novel Nonsense Mutation of the GLA Gene Associated with the Classical Phenotype of Fabry Disease.Medication adherence in Alzheimer's disease: The mediator role of mindfulness.Compensatory postural adjustments in Parkinson's disease assessed via a virtual reality environment.Role of the Visual and Auditory Systems in Postural Stability in Alzheimer's Disease.The effect of levodopa on postural stability evaluated by wearable inertial measurement units for idiopathic and vascular Parkinson's disease.Analysis of postural kinetics data using Artificial Neural Networks in Alzheimer's DiseaseDeep brain stimulation does not change neurovascular coupling in non-motor visual cortex: An autonomic and visual evoked blood flow velocity response studySANDO: Two novel mutations in POLG1 gene[Cerebrospinal fluid biomarkers for the early diagnosis of Parkinson's disease]Founder effect of Fabry disease due to p.F113L mutation: Clinical profile of a late-onset phenotypeParkinson's Disease and Fabry Disease: Clinical, Biochemical and Neuroimaging Analysis of Three PedigreesGait stride-to-stride variability and foot clearance pattern analysis in Idiopathic Parkinson's Disease and Vascular Parkinsonism
P50
Q37122857-D2EB45FC-8983-450A-8C80-990ED6C62DE4Q37547714-43407AEF-EB07-414B-BF40-360F82269B22Q37603006-64EF493B-1C70-49A4-94AA-F3B9A7CF363BQ38247402-B8539204-9F7C-400C-BABE-E322A34A0A19Q38381455-89C6054D-C19B-47D8-A085-BB3BDCAA71F7Q38790087-0FBC192E-EEAB-4D58-AC04-21FBD0CD5357Q39336499-073CE6D5-315B-4430-B9A5-CC3F91B28385Q47138882-33541F96-4E59-4D2E-B31A-108E25D23784Q47667552-744411D4-9983-4E71-921C-0D0CF28A85B5Q47729161-C2B4A831-7094-4E95-9144-17A925E1228EQ48286347-9A79BE40-4661-4A4C-8637-56C3CA5993DCQ50217339-CDD16DF4-F442-4648-A02B-4A41454BC451Q50599450-250F5B42-3553-4987-B820-79E658BA09E9Q51796715-E59130A5-9A16-4CCC-8D9A-76695FF7CCB9Q53295580-6698B001-AB1C-4E55-A4A3-D5D6E8E41B99Q53367766-520E24EA-8EE1-4750-A0F7-3FD642ED6854Q57966508-D660BBBB-D10B-4316-B56C-0D634CCF7A91Q58204299-EA031F51-6F5D-4C10-858C-92882F453338Q60169772-DC8495D4-567C-4B05-9148-41228FA87B8BQ62740569-237B43CF-0F97-45DE-9C7E-0452CCB8AC8AQ90099423-C29C0D17-0079-48D1-9ED9-6FAE8385CE47Q90593659-D722D488-7BCB-47EE-9154-6995D859201CQ92639525-46A2E52C-DF8A-44C2-9B15-140555E7FC8E
P50
description
hulumtues
@sq
promovendus
@nl
researcher
@en
հետազոտող
@hy
name
Miguel F. Gago
@ast
Miguel F. Gago
@en
Miguel F. Gago
@es
Miguel F. Gago
@sl
type
label
Miguel F. Gago
@ast
Miguel F. Gago
@en
Miguel F. Gago
@es
Miguel F. Gago
@sl
altLabel
Gago MF
@en
Miguel Fernandes Gago
@en
prefLabel
Miguel F. Gago
@ast
Miguel F. Gago
@en
Miguel F. Gago
@es
Miguel F. Gago
@sl
P1053
F-2355-2015
P1153
14421192400
P21
P2798
P31
P3829
P4012
P496
0000-0003-0894-6207